Skip to main content
Profile № 136272085 · Filing year 2024

CANCER RESEARCH AND TREATMENT FUND INC

New York, New York·EIN 13-6272085·3
Total revenue
$1.1M
Total assets
$15.2M
Total expenses
$0
Reported officers
18
Mission

CANCER RESEARCH AND TREATMENT FUND,INC.(CR&T) FUNDS RESEARCH EMPHASIZING THE CAUSE,PREVENTION,TREATMENT,AND CURE OF MYELOPROLIFERATIVE NEOPLASMS(MPNs)AND ALSOFUNDS OTHER BLOOD AND SOLID TUMOR CANCER RESEARCH.

Executive compensation

Form 990 · Schedule J · 1 reported individual · Filing year 2024

Base salaryExecutive compensation
Director
officer (unspecified)
$120k

Plus 17 unpaid individuals.

Held steady
from 2023

From $120k in 2023 to $120k in 2024.

$120k
2023
$120k
2024
Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.